iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://doi.org/10.1007/978-3-540-79088-4_7
Designer Steroids | SpringerLink
Skip to main content
Springer Nature Link
Log in

Designer Steroids

  • Chapter
  • First Online:
Doping in Sports: Biochemical Principles, Effects and Analysis

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 195))

Abstract

Anabolic steroids have been studied for over 50 years and during that time numerous compounds with a variety of functional groups have been produced and many have been published. Of these only a small number have been introduced to the pharmaceutical market. WADA has continued the work begun by the IOC banning the use of these agents within sport as performance enhancing substances. Athletes, however, continue to use these anabolic steroids but tighter testing and the introduction of unannounced sample collection has made this form of cheating harder.

In order to try to evade detection, athletes who continue to dope are having to resort to the use of a far more dangerous form of drug – the designer steroid. These steroids are manufactured to closely resemble existing known compounds, but with sufficient chemical diversity to ensure that their detection by the WADA accredited laboratories is more difficult. A worrying feature of the use of these compounds is that no data is available to evaluate either the efficacy or the safety of these substances. Many such drugs are now being made in clandestine ways (as demonstrated by the recent BALCO case) and then passed on to athletes who become the guinea pigs determining the potential of the substances as doping agents.

Methods for the detection of these new compounds are being developed using emerging techniques such as gas chromatography or liquid chromatography attached to a variety of mass spectrometry instruments. This technology as well as vigilance by laboratories and enforcement agencies can all help in early detection of designer steroids being used for doping.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Albanese AA (1969) Nutritional and metabolic effects of anabolic steroids and corticosteroids. J Am Med Wom Assoc 24(1):42–51

    CAS  PubMed  Google Scholar 

  • Albanese AA, Lorenze EJ, Orto LA, Wein EH (1968) Nutritional and metabolic effects of some newer steroids V. Norbolethone. NY State J Med 68(18):2392–2406

    CAS  Google Scholar 

  • Articles (2005), http://sport.guardian.co.uk/athletics/story/0, 1605761,00.html; http://www.antidoping.ee/failikataloog/East%20Germany%20doping%20victims...28.04.05.pdf. sighted Nov 2007

  • ASADA (2006), http://www.comlaw.gov.au/ComLaw/Legislation/Act1.nsf/0/C3977FDB55132A3FCA25713000066A85/$file/006-2006.pdf. sighted April 2008

  • BALCO articles (2006), http://www.ergogenics.org/120.html#9b; http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2006/08/05/MNG21KBVGA1.DTL. sighted April 2008

  • Bovee TFH, Lommerse JPM, Peijnenburg Ad ACM, Fernandes EA, Nielsen MWF (2008) A new highly androgen specific yeast biosensor, enabling optimisation of (Q) SAR model approaches. J Steroid Biochem Mol Biol J Steroid Biochem Mol Biol 108(1–2):121–131

    CAS  Google Scholar 

  • Bowers LD (1997) Analytical advances in detection of performance-enhancing compounds. Clin Chem 43(7):1299–1304

    CAS  PubMed  Google Scholar 

  • Catlin DH, Ahrens BD, Kucherova Y (2002) Detection of norbolethone, an anabolic steroid never marketed, in athletes’ urine. Rapid Commun Mass Spectrom 16:1273–1275

    Article  CAS  PubMed  Google Scholar 

  • Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang Y-C, Hatton CK (2004) Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom 18:1245–1249

    Article  CAS  PubMed  Google Scholar 

  • Corrigan B, Kazlauskas R (2003) Medication use in athletes selected for doping control at the Sydney Olympics. Clin J Sports Med 13:33–40

    Article  Google Scholar 

  • Covey DF, Hood WF (1981) Enzyme-generated intermediates derived from 4-androstene-3, 6, 17-triene and 1, 4, 6-androstatriene-3, 17-dione cause a time-dependent decrease in human placental aromatase activity. Endocrinology 108:1597–1599

    Article  CAS  PubMed  Google Scholar 

  • Death AK, McGrath KCY, Kazlauskas R, Handelsman DJ (2004) Tetrahydrogestrinone (THG) is a potent androgen and progestin. J Clin Endocrinol Metab 89(5):2498–2500

    Article  CAS  PubMed  Google Scholar 

  • Desaulles PA, Schärr B (1967) Properties of a new highly active anabolic steroid CIBA 36,644-Ba. Proc Int Congr Horm Steroids 32:541–547

    Google Scholar 

  • Dorfman RI (1968) Relative potency of steroids on the rat levator ani muscle. J Am Med Wom Assoc 23(8):725–733

    CAS  PubMed  Google Scholar 

  • Dörner G (1965) 4-Chlor-Δ1-Methyltestosteron (Oral-Turinabol), ein neues oral wirksames Anabolikum. Dtsch Gesundheitswes 20:670–694

    Google Scholar 

  • eMIMS Version 5.00.0248, MIMS, CMPMedica Australia PTY,LTD, ACN 050 695 157

    Google Scholar 

  • Fourcroy J (2006) Designer steroids: past, present and future. Curr Opin Endocrinol Diabet 13:306–309

    Article  CAS  Google Scholar 

  • Friedel A, Geyer H, Kamber M, Laudenbach-Leschowsky U, Schänzer W, Thevis M, Vollmer G, Zierau O, Diel P (2006) Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver. Toxicol Lett 164(1):16–23

    Article  CAS  PubMed  Google Scholar 

  • Gaido KW, Leonard LS, Lovell S, Gould JC, Babai D, Portier CJ, McDonnell DP (1997) Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol Appl Pharmacol 143:205–212

    Article  CAS  PubMed  Google Scholar 

  • Georgakopoulos CG, Vonaparti A, Stamou M, Kiousi P, Lyris E, Angelis YS, Tsoupras G, Wuest B, Niesen MWF, Panderi I, Koupparis M (2007) Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids. Rapid Commun Mass Spectrom 21:2439–2446

    Article  CAS  PubMed  Google Scholar 

  • Geyer H, Parr MK, Mareck U, Reinhart U, Schrader Y, Schänzer W (2004) Analysis of non-hormonal nutritional supplements for anabolic-androgenic steroids – results of an international study. Int J Sports Med 25(2):124–129

    Article  CAS  PubMed  Google Scholar 

  • Horning S, Donike M (1994) High-resolution GC/MS. In: Donike et al (ed) Recent advances in doping analysis, Proceedings of the 11th cologne workshop on dope analysis 7th to 12th March 1993, pp 155–162

    Google Scholar 

  • Joska J, Fajkoš J, Šorm F (1968) On steroids. CXVII. 5, 7-cyclosteroids. III. 5, 7-cyclosteroid androgen analogues. Collect Czechoslov Chem Commun 33:3342–3355

    CAS  Google Scholar 

  • Kaneko H, Nakamura K, Yamato Y, Kurokawa M (1969) Synthesis and structure-activity relationships of 7a-alkylthioandrostanes. Chem Pharm Bull 17(1):11–22

    CAS  PubMed  Google Scholar 

  • Kazlauskas R (2006) Miscellaneous projects in sports drug testing at the National Measurement Institute, Australia. In: Schänzer et al (ed) Recent advances in doping analysis (14). Proceedings of the Manfred Donike Workshop, 24th Cologne Workshop on Dope Analysis 4th to 9th June 2006, pp 129–140

    Google Scholar 

  • Khripach VA, Zhabinskii VN, Kuchto AI, Zhiburtovich YY, Fando GP, Lyakhov AS, Govorova AA, Groen MB, van der Louw J, de Groot A (2004) Synthesis of 13, 14-secotestosterone derivatives. Steroids 69:501–509

    Article  CAS  PubMed  Google Scholar 

  • Khripach VA, Zhabinskii VN, Fando GP, Kuchto AI, Khripach NB, Groen MB, van der Louw J, de Groot A (2006) A new type of steroids with a cyclobutane fragment in the AB-ring moiety. Steroids 71:445–449

    Article  CAS  PubMed  Google Scholar 

  • Klimstra PD (1969) Androgenic and anabolic steroids. Intra-Sci Chem Rep 3(1–2):83–103

    CAS  Google Scholar 

  • Kochakian CD (1950) Comparison of protein anabolic property of various androgens in the castrated rat. Am J Physiol 160:53–61

    CAS  PubMed  Google Scholar 

  • Kochakian CD (1976) Anabolic-androgenic steroids. In: Kochakian CD (ed) Metabolic effects of anabolic-androgenic steroids in experimental animals, vol 43. Springer, Berlin, pp 5 – 44

    Google Scholar 

  • Little K (1970) Interaction between catabolic and anabolic steroids. Curr Therapeut Res 12(10):658–676

    CAS  Google Scholar 

  • McRobb L, Handelsman DJ, Kazlauskas R, Wilkinson S, McLeod MD, Heather AK (2008) Structure–activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay. J Steroid Biochem Mol Biol. doi:10.1016/j.jsbmb.2007.10.008, Feb 12

    PubMed  Google Scholar 

  • Miyake T, Takeda K (1967) Epithioandrostanol, a new type of anti-estrogen. Proc Int Congr Horm Steroids 2nd, Meeting Date 1966, pp 616–627

    Google Scholar 

  • Miyake T, Komeno T, Takeda K (1969) 2α, 3α -Epi thio-5α -androstan-17β -ol and related compounds. III. Structure–activity relations. Shionogi Kenkyusho Nenpo 19:39–50

    CAS  Google Scholar 

  • Munoz-Guerra J, Carreras D, Soriano C, Rodriguez C, Rodriguez AF (1977) Use of ion trap (GC–MS–MS) mass spectrometry for detection and confirmation of anabolic substances at low concentration levels in doping analysis. In: Schänzer et al (ed) Recent advances in doping analysis (5), Proceedings of the Manfred Donike workshop 15th cologne workshop on dope analysis 23rd to 28th February 1997, pp 169–184

    Google Scholar 

  • Nielen MWF, Bovee TFH, van Engelen MC, Rutgers P, Hamers ARM, van Rhijn JA, Hoogenboom LAP (2006) Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole Time-of-Flight Mass spectrometry identification. Anal Chem 78(2):424–431

    Article  CAS  PubMed  Google Scholar 

  • Nieschlag E, Behre HM (eds) (2004) Testosterone – action, deficiency, substitution. Cambridge University Press, Cambridge University Press, Cambridge, p 693–694

    Google Scholar 

  • Numazawa M, Yamaguchi S (1999) Synthesis and structure-activity relationships of 6-phenylaliphatic substituted C19 steroids having a 1, 4-diene, 4, 6-diene, or 1, 4, 6-triene structure as aromatase inhibitors. Steroids 64:187–196

    Article  CAS  PubMed  Google Scholar 

  • Parr M, Kazlauskas R, Schlörer N, Opfermann G, Piper T, Schulze G, Schänzer W (2008) 6α-Methylandrostenedione: gas chromatographic mass spectrometric detection in doping control. Rapid Commun Mass Spectrom 22(3):321–329

    Article  CAS  PubMed  Google Scholar 

  • Rodchenkov G, Sobolevsky T, Sizol V (2006) New designer anabolic steroids from internet. In: Schänzer et al (ed) Recent advances in doping analysis (14), Proceedings of the Manfred Donike workshop 24th cologne workshop on dope analysis 4th to 9th June 2006, pp 141–150

    Google Scholar 

  • Schanzer W, Delahaut P, Geyer H, Machnik M, Horning S (1996) Long-term detection and identification of metandienone and stanozolol abuse in athletes by gas chromatography-high-resolution mass spectrometry. J Chromatogr B 687:93–108

    Article  CAS  Google Scholar 

  • Schrader Y, Thevis M, Schänzer W (2006) Quantitative determination of metabolic products of 19-norandrostenediol in human plasma using gas chromatography/mass spectrometry. Drug Metab Dispos 34(8):1328–1335

    Article  CAS  PubMed  Google Scholar 

  • Schwarzel WC, Kruggel WG, Brodie HJ (1973) Studies on the mechanism of estrogen biosynthesis. VIII. The development of inhibitors of the enzyme system in human placenta. Endocrinology 92:866–880

    Article  CAS  PubMed  Google Scholar 

  • Sekera MH, Ahrens BD, Chang Y-C, Starcevic B, Georgakopoulos C, Catlin DH (2005) Another designer steroid: discovery, synthesis, and detection of ‘madol’ in urine. Rapid Commun Mass Spectrom 19:781–784

    Article  CAS  PubMed  Google Scholar 

  • Smith H (1965) Total Synthesis of steroid hormones. Trans NY Acad Sci 27(5):546

    CAS  Google Scholar 

  • Thevis M (2007) Current role of LC–MS(/MS) in doping control. Anal Bioanal Chem 388(7):1351–1358

    Article  CAS  PubMed  Google Scholar 

  • Thevis M, Schänzer W (2005) Mass spectrometry in doping control analysis. Curr Org Chem 9(9):825–848

    Article  CAS  Google Scholar 

  • Thevis M, Geyer H, Mareck U, Schänzer W (2005) Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. J Mass Spectrom 40:955–962

    Article  CAS  PubMed  Google Scholar 

  • Ueno K, Ohta G (1967) Investigations on steroids VII, derivatives of 17β-hydroxyandrostano[2, 3-c]furazan substituted at position 16. Chem Pharm Bull 15(4):518–522

    CAS  PubMed  Google Scholar 

  • Ungerleider S (2001) Faust’s Gold: inside the East German doping machine, Thomas Dunne Books. St. Martin’s Press, New York

    Google Scholar 

  • USA Today (2007) http://www.usatoday.com/sports/balco-timeline.htm. sighted April 2008

  • USADA (2005) http://www.usantidoping.org/files/active/who/annual_report_2005.pdf. sighted April 2008

  • Van Eenoo P, Delbeke FT (2006) Metabolism and excretion of anabolic steroids in doping control–new steroids and new insights. J Steroid Biochem Mol Biol 101:161–178

    Article  PubMed  Google Scholar 

  • Von Weichert R, Steinbeck H, Elger W, Neumann F (1967) Wirkungen und Struktur neuer antiandogener Steroide. Arzneimittel-Forsch 17:1103–1116

    Google Scholar 

  • WADA (2008); http://www.wada-ama.org/rtecontent/document/2008_List_En.pdf.

  • WADA (2009); http://www.wada-ama.org/rtecontent/document/2009_Prohibited_List_ENG_Final_20_Sept_08.pdf

  • WADA TD2003IDCR (2008); http://www.wada-ama.org/rtecontent/document/criteria_1_2.pdf. sighted April 2008

  • Wolf ME, Chang H-H (1970) Synthesis and myotrophic-androgenic activity of 17β-hydroxy-5α-androst-8(14)-en-3-one derivatives. J Med Chem 14(5):967–968

    Article  Google Scholar 

  • Wolf ME, Zanati G (1969) Thia steroids. I. 2-Thia-A-nor-5α-androstan-17β-ol, an active androgen. J Med Chem 12:629–631

    Article  Google Scholar 

  • Wolf ME, Zanati G (1970) Preparation and androgenic activity of novel heterocyclic steroids. Experientia 26(10):115–116

    Google Scholar 

  • Yuan X, Forman BM (2005) Detection of designer drugs. Nuclear Receptor Signaling 3: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid = 1402217. sighted January 2009

  • Zanati G, Wolf ME (1971) Heterocyclic steroids. 2. Synthesis and androgenic activity of A-Ring oxaandrostanes. J Med Chem 14(10):958–961

    Article  CAS  PubMed  Google Scholar 

  • Zanati G, Wolf ME (1972) Heterocyclic steroids. 4. Synthesis and androgenic activity of A-Ring homosteroids. J Med Chem 15(4):368–369

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Measurement Institute, Australian Sports Drug Testing Laboratory, 1 Suakin St., Pymble, NSW, 2073, Australia

    Ray Kazlauskas

Authors
  1. Ray Kazlauskas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ray Kazlauskas .

Editor information

Editors and Affiliations

  1. Sportbiochemie Dresden, Institut für Dopinganalytik und, Dresdner Straße 12, Kreischa, 01731, Germany

    Detlef Thieme

  2. Gamle Trondheimsvei 39, Hagan, 1481, Norway

    Peter Hemmersbach

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kazlauskas, R. (2010). Designer Steroids. In: Thieme, D., Hemmersbach, P. (eds) Doping in Sports: Biochemical Principles, Effects and Analysis. Handbook of Experimental Pharmacology, vol 195. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79088-4_7

Download citation

Publish with us

Policies and ethics

Search

Navigation